insights_auto
Why is ACAD down 3.71%?
Dive Deeperchevron_right
ACAD:NASDAQ
ACADIA Pharmaceuticals Inc
$25.43
arrow_downward
-3.71%(-0.98) 1D
$25.50
arrow_upward
+0.28% (+0.070)bedtimeAfter hours
Closed: Sep 23, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ACAD...
Open
$26.41
High
$26.51
Low
$24.93
Mkt. cap
4.38B
Avg. vol.
1.52M
Volume
1.31M
P/E ratio
11.49
52-wk high
$30.96
52-wk low
$19.69
EPS
$2.21
Beta
0.86
Shares outstanding
172.31M
No. of employees
797
Open
$26.41
High
$26.51
Low
$24.93
Mkt. cap
4.38B
Avg. vol.
1.52M
Volume
1.31M
P/E ratio
11.49
52-wk high
$30.96
52-wk low
$19.69
EPS
$2.21
Beta
0.86
Shares outstanding
172.31M
No. of employees
797
News stories
From web sources and news partners
Investing.com
·
13 hours ago
Oppenheimer maintains Perform rating on Acadia stock ahead of trial
Profile
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California. Wikipedia
About ACADIA Pharmaceuticals Inc
CEOCatherine Owen Adams
Employees797
Founded1993
HeadquartersSan Diego, California, United States
SectorBiotechnology
Websiteacadia.com